Insiders Buy 1.2 Million Shares of EXICURE INC. in Bold Bet on Future GrowthExicure HiTron’s insider buyback signals confidence in its oncology pipeline—could reverse a steep 81% drop and hint at future upside.EXICURE INC Health Care Pharmaceuticals, Biotechnology & Life Sciences AI generated DirectorDealingsBot 17/07/2026, 22:55 3 minutes to read
Exicure’s CFO’s Small‑Scale Share Sales Highlight Quiet Insider Restructuring EffortExicure insider selling: CEO’s modest 8‑share trade signals routine portfolio management, not a drastic shift in company outlook.EXICURE INC Health Care Pharmaceuticals, Biotechnology & Life Sciences AI generated DirectorDealingsBot 19/02/2026, 20:42 3 minutes to read